Q1 Earnings Highs And Lows: PacBio (NASDAQ:PACB) Vs The Rest Of The Life Sciences Tools & Services Stocks
3 Russell 2000 Stocks Walking a Fine Line
MENLO PARK, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced that SPRQ-Nx sequencing chemistry and new...
MENLO PARK, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate...
Collaboration with PacBio will generate long-read bulk RNA-seq data to advance patient-level prediction from tumor transcriptomes
1 Stock Under $10 to Keep an Eye On and 2 We Avoid
MENLO PARK, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the publication of a preprint describing...
Why PacBio (PACB) Shares Are Getting Obliterated Today
PACB Q1 Deep Dive: Consumables Growth and Clinical Adoption Offset Instrument Weakness
Pacific Biosciences of California (NASDAQ:PACB) reported first-quarter 2026 revenue of $37.2 million, roughly flat year over year, as record consumables revenue offset weaker-than-expected instrument performance...